Pitcairn’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-6,085
| Closed | -$362K | – | 583 |
|
|
2020
Q3 | $362K | Sell |
6,085
-893
| -13% | -$53.1K | 0.03% | 318 |
|
|
2020
Q2 | $487K | Buy |
6,978
+223
| +3% | +$15.6K | 0.05% | 234 |
|
|
2020
Q1 | $307K | Buy |
6,755
+2,938
| +77% | +$134K | 0.04% | 294 |
|
|
2019
Q4 | $249K | Sell |
3,817
-255
| -6% | -$16.6K | 0.02% | 459 |
|
|
2019
Q3 | $252K | Buy |
4,072
+638
| +19% | +$39.5K | 0.02% | 452 |
|
|
2019
Q2 | $245K | Sell |
3,434
-27
| -0.8% | -$1.93K | 0.02% | 472 |
|
|
2019
Q1 | $272K | Buy |
3,461
+915
| +36% | +$71.9K | 0.03% | 389 |
|
|
2018
Q4 | $215K | Sell |
2,546
-593
| -19% | -$50.1K | 0.02% | 399 |
|
|
2018
Q3 | $537K | Sell |
3,139
-226
| -7% | -$38.7K | 0.06% | 234 |
|
|
2018
Q2 | $435K | Sell |
3,365
-617
| -15% | -$79.8K | 0.05% | 281 |
|
|
2018
Q1 | $410K | Buy |
3,982
+1,138
| +40% | +$117K | 0.04% | 283 |
|
|
2017
Q4 | $243K | Sell |
2,844
-93
| -3% | -$7.95K | 0.02% | 436 |
|
|
2017
Q3 | $250K | Sell |
2,937
-123
| -4% | -$10.5K | 0.03% | 405 |
|
|
2017
Q2 | $232K | Sell |
3,060
-127
| -4% | -$9.63K | 0.03% | 405 |
|
|
2017
Q1 | $210K | Sell |
3,187
-85
| -3% | -$5.6K | 0.03% | 460 |
|
|
2016
Q4 | $207K | Sell |
3,272
-370
| -10% | -$23.4K | 0.03% | 481 |
|
|
2016
Q3 | $232K | Buy |
3,642
+2
| +0.1% | +$127 | 0.03% | 438 |
|
|
2016
Q2 | $271K | Sell |
3,640
-161
| -4% | -$12K | 0.03% | 364 |
|
|
2016
Q1 | $254K | Buy |
3,801
+696
| +22% | +$46.5K | 0.03% | 385 |
|
|
2015
Q4 | $210K | Sell |
3,105
-640
| -17% | -$43.3K | 0.02% | 408 |
|
|
2015
Q3 | $200K | Sell |
3,745
-314
| -8% | -$16.8K | 0.03% | 391 |
|
|
2015
Q2 | $256K | Sell |
4,059
-739
| -15% | -$46.6K | 0.03% | 398 |
|
|
2015
Q1 | $231K | Buy |
+4,798
| New | +$231K | 0.03% | 432 |
|